Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol in Depression
NCT03384329Phase 4Completed
- Sponsor
- Russian Academy of Sciences
- Start
- Jul 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of resveratrol in major depressive disorder (MDD), sponsored by Russian Academy of Sciences. Started Jul 2018; status: completed.
02
Drugs
resveratrol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03384329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384329.